日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Effect of C-Reactive Protein/Lymphocyte Ratio (CLR) on PFS in Metastatic Breast Cancer Patients Treated with CDK4/6 Inhibitors: A Novel Biomarker

C反应蛋白/淋巴细胞比值(CLR)对接受CDK4/6抑制剂治疗的转移性乳腺癌患者无进展生存期的影响:一种新型生物标志物

Buyukbayram, Mehmet Emin; Hannarici, Zekeriya; Duzkopru, Yakup; Turhan, Aykut; Caglar, Alperen Akansel; Coban Esdur, Pınar; Bilici, Mehmet; Tekin, Salim Basol; Yazılıtaş, Doğan

A novel prognostic biomarker in progression free survival for patients with cervical cancer, glucose to c-reactive protein ratio (GCR)

葡萄糖与 C 反应蛋白比值 (GCR) 是宫颈癌患者无进展生存期的一种新型预后生物标志物

Buyukbayram, Mehmet Emin; Hannarici, Zekeriya; Turhan, Aykut; Caglar, Alperen Akansel; Esdur, Pınar Çoban; Bilici, Mehmet; Tekin, Salim Basol; Erdemci, Burak

Inflammatory parameters in NSCLC with driver mutation

非小细胞肺癌驱动基因突变患者的炎症参数

Buyukbayram, Mehmet Emin; Hannarici, Zekeriya; Yilmaz, Ali; Turhan, Aykut; Caglar, Alperen Akansel; Esdur, Pınar Coban; Bilici, Mehmet; Tekin, Salim Basol

Characteristics of Newly Diagnosed Hepatocellular Carcinoma Patients Across Turkey: Prospective Multicenter Observational 3K Registry Study

土耳其新诊断肝细胞癌患者的特征:前瞻性多中心观察性3K注册研究

Akarca, Ulus Salih; Unsal, Belkis; Sezgin, Orhan; Yalcin, Kendal; Akdogan, Meral; Gonen, Can; Gunduz, Feyza; Ozenirler, Seren; Sonsuz, Abdullah; Dincer, Dinc; Tekin, Salim Basol; Yucel, Idris; Akbulut, Hakan; Alkım, Canan; Ozyilkan, Ozgur; Baygul, Arzu; Cevik, Zeynep Merve; Idilman, Ramazan; Study Group, On Behalf Of K Registry

Are We Late in the Diagnosis of Malignities Occurring in Solid Organ Transplant Patients? 11 Years' Experience

我们是否错过了实体器官移植患者恶性肿瘤的诊断时机?11年经验

Turkeli, Mehmet; Simsek, Melih; Aldemir, Mehmet Naci; Yildirim, Nilgun; Cankaya, Erdem; Erdemci, Burak; Bilici, Mehmet; Tekin, Salim Basol; Arslan, Sukru; Korkut, Ercan